| abstract |
The invention relates to a 4-benzyl piperazine ethyliminum acetyl (imine methyl benzene) hydrazine compound, as well as a preparation method, a drug composition and a use of the compound. The compound has a structure shown in a right formula, wherein X can be pyridinecarboxylester (ROCO), and R1, R2, R3 and R4 can be hydrogen atoms, hydroxyl, halogen, alkyl or carboxyl respectively and independently. Animal in vivo-vitro cell experiments prove that the compound can be used for treating cancer. |